Reevaluation of the Bayesian network model to support immunotherapy decision-making in recurrent/metastatic head and neck squamous cell carcinoma. (PubMed, Int J Comput Assist Radiol Surg) - Sep 26, 2026 - "The immune-oncologic BN offers a promising approach to enhance personalized immunotherapy selection in RM-HNSCC patients by integrating diverse clinical variables into an interpretable decision support framework. The results support further prospective validation and clinical integration. Given the increasing complexity of biomarker-driven therapy, probabilistic models may contribute to more consistent and evidence-aligned treatment decisions."
IO biomarker • Journal • Head and Neck Cancer • Oncology • Solid Tumor • Squamous Cell Carcinoma • Squamous Cell Carcinoma of Head and Neck
|
|
Andreas Dietz; Jan Gaebel; Johannes Stoehr; Matthaeus Stoehr
|